Table 1.

Baseline Characteristics of Study Participants by Treatment Groupa

No. (%)
ControlLTOT
Characteristic(n = 201)(n = 201)PSDiffb
Age (years)
 21 to 4959 (29.4)57 (28.4)
 50 to 64101 (50.2)90 (44.8)0.290.05
 65 to 7941 (20.4)54 (26.9)
Gender
 Man54 (26.9)51 (25.4)0.730.03
 Woman147 (73.1)150 (74.6)
Race
 White152 (75.6)159 (79.1)
 Black39 (19.4)38 (18.9)0.250.05
 Other10 (5.0)4 (2.0)
Duration of low back pain (years)
 ≤551 (25.4)48 (23.9)0.730.03
 >5150 (74.6)153 (76.1)
Pain catastrophizing
 0 to 1794 (46.8)94 (46.8)
 18 to 3468 (33.8)68 (33.8)>0.990.00
 35 to 5239 (19.4)39 (19.4)
Pain self-efficacy
 0 to 2046 (22.9)59 (29.4)
 21 to 4089 (44.3)91 (45.3)0.170.07
 41 to 6066 (32.8)51 (25.4)
Chronic widespread pain
 No137 (68.2)141 (70.1)0.670.04
 Yes64 (31.8)60 (29.9)
Ever had work loss ≥1 month due to low back pain
 No103 (51.2)105 (52.2)0.840.02
 Yes98 (48.8)96 (47.8)
Ever received disability or workers' compensation benefits due to low back pain
 No146 (72.6)144 (71.6)0.820.02
 Yes55 (27.4)57 (28.4)
Ever filed a law suit or legal claim due to low back pain
 No182 (90.5)183 (91.0)0.860.02
 Yes19 (9.5)18 (9.0)
Prior low back surgery
 No159 (79.1)156 (77.6)0.720.04
 Yes42 (20.9)45 (22.4)
Health-related quality of life, mean (SD)58.01 (7.16)58.71 (6.36)0.300.10
Low back pain intensity, mean (SD)6.39 (1.67)6.39 (1.92)0.980.00
Back-related disability, mean (SD)15.32 (5.49)15.41 (5.23)0.870.02
Pain impact, mean (SD)32.57 (8.75)32.88 (8.24)0.720.04
  • Abbreviation: LTOT, long-term opioid therapy.

  • Notes: aTreatment groups were matched on propensity score using a logistic regression model that included all variables in the table, with a caliper width of .001. Health-related quality of life involved a composite measure of anxiety, depression, fatigue, sleep disturbance, and pain interference. Higher values represented worse quality of life.

  • bMagnitude of the standardized difference.